Moderna's mRNA flu vaccine backed by FDA advisers
- Posted on June 18, 2026
- By Bing News
- 0 Views
- 1 min read
Moderna's mRNA flu vaccine backed by FDA advisers
By Christy Santhosh and Mariam Sunny June 18 (Reuters) - Advisers to the U.S. Food and Drug Administration on Thursday backed approval of Moderna's flu vaccine for adults aged 50 and older, saying its benefits outweigh the risks, boosting the company's chances of launching the first mRNA-based seasonal flu shot. The nine panel members voted unanimously in favor of use of Moderna's shot mFlusiva
